Madrigal Pharmaceuticals Inc MDGL Valuation Ratios and Share Stats

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Madrigal Pharmaceuticals Inc (MDGL)
Madrigal Pharmaceuticals Inc (MDGL) Financials

Madrigal Pharmaceuticals Inc (MDGL)

319.305

-9.86

( -2.99% )

Updated: 10:38:24

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-26.682	-9.682	-18.102	-55.481	-86.323	-92.891	-74.494	-55.371
Return on Equity (%)	-28.494	-9.954	-18.79	-61.61	-110.919	-150.116	-123.981	-80.346
Return on Invested Capital (%)	-29.325	-12.342	-21.257	-62.959	-111.211	-132.602	-99.153	-71.494
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-250.493
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-258.638
Book Value Per Share	11.253	27.446	23.942	13.73	10.282	9.834	18.668	31.525
Earnings Per Share	-1.923	-1.888	-4.825	-11.571	-12.68	-14.714	-17.208	-19.592
Cash Per Share	9.176	3.302	2.684	3.09	1.902	16.517	4.602	4.206
Working Capital Per Share	11.234	27.433	23.856	13.652	10.216	12.229	23.89	36.318
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	7.313
EBIT Per Share	-1.923	-1.888	-4.825	-11.571	-12.68	-14.714	-17.208	-19.592
EBITDA Per Share	-1.923	-1.888	-4.825	-11.571	-12.68	-14.714	-17.208	-19.592
Free Cash Flow Per Share	-1.92	-1.892	-4.821	-11.579	-12.69	-14.726	-17.164	-19.366

Liquidity Ratios

Year End December 30 2024	2017	2018	2019	2020	2021	2022	2023	2024
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	14.23M	15.41M	15.43M	15.51M	17.1M	18.1M	N/A	N/A

Key Stats and Ratios

Year End December 30 2024	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	7.27B
Price to Earnings Ratio	-15.49
Price to Sales Ratio	40.05
Price to Cash Ratio	72.14
Price to Book Ratio	9.56
Dividend Yield	-

Share Statistics

Shares Outstanding	22.08M
Average Volume (1 week)	483.73k
Average Volume (1 Month)	431.25k
52 Week Change	23.82%
52 Week High	377.46
52 Week Low	189.00

More Ratios Coming Soon!

Madrigal Pharmaceuticals

Kodiak Sciences

Abbott Laboratories

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions